title: Biochanin A reduces drug-induced p75NTR expression and enhances cell survival: a new in vitro assay for screening inhibitors of p75NTR expression.
abstract: Following spinal cord injury (SCI) or peripheral neuropathy, increased levels of the p75(NTR) death receptor initiate the signal transduction cascade leading to cell death. Investigations of compounds that may ameliorate neuronal cell death have largely used rodent models, which are time consuming, expensive, and cumbersome to perform. Previous studies had demonstrated that steroids, particularly dexamethasone and its analog methylprednisolone sodium succinate, exhibit limited neuroprotective effects against neuronal injury. Significantly, many naturally occurring nonsteroidal plant compounds exhibit structural overlap with steroids. In this report, we present an in vitro cellular screen model to practically examine the efficacy of various phytoestrogens in modulating the ibuprofen-induced expression of p75(NTR) and reduced cell survival of CCFSTTG1 and U87MG cells in a rescue (postinjury) or prevention (preinjury) regimen. We show that the phytoestrogen, biochanin A, and, to a lesser extent, genistein are more effective than dexamethasone at reducing p75(NTR) expression and improving the viability of U87MG and CCFSTTG1 before and after p75(NTR) induction. Furthermore, these studies implicate biochanin A's inactivation of p38-MAPK as a possible contributor to reducing p75(NTR) with associated increased cell survival. This new in vitro assay facilitates a more time-efficient screening of compounds to suppress p75(NTR) expression and increase neuronal cell viability prior to their evaluation in animal models of neurological diseases.
authors.affiliation: Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
authors.forename: Lara H
authors.initials: LH
authors.lastname: El Touny
authors.forename: Fraser
authors.initials: F
authors.lastname: Henderson
authors.forename: Daniel
authors.initials: D
authors.lastname: Djakiew
mesh_terms: D001681:Biological Assay / Q000379:methods*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004789:Enzyme Activation / Q000187:drug effects; D019833:Genistein / Q000494:pharmacology*; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology*; D034741:RNA, Small Interfering / Q000378:metabolism; D017475:Receptors, Nerve Growth Factor / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D013997:Time Factors; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism
chemical_list: D034741:RNA, Small Interfering; D017475:Receptors, Nerve Growth Factor; D003907:Dexamethasone; D019833:Genistein; D048051:p38 Mitogen-Activated Protein Kinases; C004541:biochanin A; D007052:Ibuprofen
references.citation: Science. 1994 Sep 9;265(5178):1596-9
references.pmid: 8079174
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16379-84
references.pmid: 16260722
references.citation: Mol Carcinog. 2001 May;31(1):46-55
references.pmid: 11398197
references.citation: Exp Neurol. 2003 Oct;183(2):286-97
references.pmid: 14552870
references.citation: Brain Res Brain Res Rev. 2001 Nov;37(1-3):372-82
references.pmid: 11744101
references.citation: Cancer Res. 2007 Dec 1;67(23):11402-10
references.pmid: 18056468
references.citation: Cancer Res. 2004 Sep 1;64(17):6207-13
references.pmid: 15342406
references.citation: Physiol Rev. 1999 Jan;79(1):143-80
references.pmid: 9922370
references.citation: Cancer Res. 2007 Apr 1;67(7):3254-62
references.pmid: 17409433
references.citation: Nutr Rev. 2003 Jan;61(1):1-33
references.pmid: 12638461
references.citation: Brain Res. 2007 Mar 16;1137(1):146-52
references.pmid: 17204255
references.citation: Cleve Clin J Med. 2004 Feb;71 Suppl 2:S4-10
references.pmid: 15379294
references.citation: Ann Thorac Surg. 2003 Jul;76(1):315-21
references.pmid: 12842576
references.citation: Nat Neurosci. 2002 Nov;5(11):1131-6
references.pmid: 12404007
references.citation: Spine (Phila Pa 1976). 2001 Feb 15;26(4):426-30
references.pmid: 11224891
references.citation: J Neurosci. 2007 Jul 18;27(29):7751-61
references.pmid: 17634369
references.citation: Biochem Biophys Res Commun. 2006 Mar 24;341(4):1184-92
references.pmid: 16460673
references.citation: Am J Phys Med Rehabil. 2006 Aug;85(8):678-84; quiz 685-7
references.pmid: 16865023
references.citation: J Comp Neurol. 1993 Dec 22;338(4):560-74
references.pmid: 8132861
references.citation: J Neurosci. 2001 May 15;21(10):3492-502
references.pmid: 11331378
references.citation: Clin Cancer Res. 2000 Jan;6(1):230-6
references.pmid: 10656454
references.citation: Brain Res Mol Brain Res. 2001 Feb 19;87(1):61-70
references.pmid: 11223160
references.citation: Pharmacol Ther. 2007 Oct;116(1):77-106
references.pmid: 17659348
references.citation: J Neurotrauma. 2000 Oct;17(10):915-25
references.pmid: 11063057
references.citation: Mol Pain. 2007 Nov 01;3:33
references.pmid: 17974036
references.citation: Pharm Res. 2008 Sep;25(9):2158-63
references.pmid: 18454305
references.citation: Trends Neurosci. 2005 Jan;28(1):5-11
references.pmid: 15626491
references.citation: Exp Neurol. 2008 Oct;213(2):257-67
references.pmid: 18590729
references.citation: J Neurotrauma. 2006 Jun;23(6):830-52
references.pmid: 16774470
references.citation: Food Addit Contam. 1985 Apr-Jun;2(2):73-106
references.pmid: 4018320
references.citation: Endocrinology. 1997 Mar;138(3):863-70
references.pmid: 9048584
references.citation: Spine (Phila Pa 1976). 2006 Dec 15;31(26):2992-6; discussion 2997
references.pmid: 17172994
references.citation: J Neurochem. 2003 Mar;84(6):1340-8
references.pmid: 12614334
references.citation: J Nutr. 2003 Jul;133(7):2367-76
references.pmid: 12840208
references.citation: Spine J. 2004 Jul-Aug;4(4):451-64
references.pmid: 15246307
references.citation: Exp Neurol. 1996 Jan;137(1):119-26
references.pmid: 8566203
references.citation: Int J Cancer. 2003 May 20;105(1):47-52
references.pmid: 12672029
references.citation: J Neurosurg. 1991 Jul;75(1):15-26
references.pmid: 2045903
references.citation: Pharmacol Rev. 2001 Mar;53(1):135-59
references.pmid: 11171943
references.citation: AAPS J. 2006 Jul 07;8(3):E433-42
references.pmid: 17025260
references.citation: Eur J Neurosci. 1994 May 1;6(5):712-24
references.pmid: 8075816
references.citation: J Neurosci Res. 2001 Apr 1;64(1):11-7
references.pmid: 11276046
references.citation: Science. 1996 Apr 26;272(5261):542-5
references.pmid: 8614802
references.citation: Exp Cell Res. 2005 Mar 10;304(1):69-80
references.pmid: 15707575
references.citation: J Altern Complement Med. 2008 Apr;14(3):287-97
references.pmid: 18370585
references.citation: JAMA. 1997 May 28;277(20):1597-604
references.pmid: 9168289
references.citation: J Neurosci. 2006 Apr 19;26(16):4308-17
references.pmid: 16624951
references.citation: Acta Anaesthesiol Belg. 1987;38(4):405-9
references.pmid: 3327343